Haijiao Zhang | Cellular Stress Response | Best Researcher Award

Published on by Cell Biologist

Assist. Prof. Dr. Haijiao Zhang | Cellular Stress Response | Best Researcher Award

Assist. Prof. Dr. Haijiao Zhang , Oregon Health & Science University , United States

Haijiao Zhang is an Assistant Professor at Oregon Health & Science University, specializing in oncological sciences. With a background in medicine and extensive research experience, Zhang has contributed significantly to leukemia studies and cancer therapies. After completing his undergraduate studies at Jilin University, he pursued advanced degrees at Hannover Medical School and the Knight Cancer Institute. Zhang’s work focuses on uncovering genetic mechanisms and drug resistance in blood cancers, particularly acute myeloid leukemia (AML) and chronic neutrophilic leukemia (CNL). His research has led to several groundbreaking discoveries and publications in prestigious journals, advancing our understanding of cancer genomics and treatment resistance. As a postdoctoral fellow, Zhang discovered new mechanisms linked to CFS3R mutations, contributing to novel therapeutic strategies. His dedication to precision medicine continues to shape the future of cancer research.

Publication Profile: 

Orcid

Strengths for the Award:

  1. Academic and Professional Excellence: Haijiao Zhang has demonstrated significant expertise in oncological sciences, specifically focusing on cancer genomics, tumor biology, and drug resistance mechanisms. Their progression from a postdoctoral fellow to an assistant professor at Oregon Health & Science University (OHSU) highlights their leadership and dedication to advancing cancer research.

  2. Groundbreaking Research Contributions: Dr. Zhang has been pivotal in uncovering molecular mechanisms behind drug resistance in cancers such as acute myeloid leukemia (AML) and chronic neutrophilic leukemia (CNL). For instance, their discovery of diverse non-FLT3 molecular mechanisms of resistance to crenolanib in AML is a valuable contribution to understanding treatment resistance.

  3. Publication Record: Dr. Zhang has an impressive record of high-impact publications in peer-reviewed journals, including Blood, Cancer Cell, Signal Transduction and Targeted Therapy, and Nature Cancer. These publications often tackle critical challenges in cancer treatment, including mechanisms of drug resistance and potential therapeutic targets, which are directly relevant to the clinical treatment of leukemia and other cancers.

  4. Innovative Scholarship: Their research on the genomic landscape of neutrophilic leukemias and biomarkers predicting venetoclax efficacy showcases a forward-thinking approach to precision medicine. This positions Dr. Zhang as a leading researcher in biomarker identification and targeted cancer therapies.

  5. Grants and Funding: Dr. Zhang’s ability to secure significant funding, such as the R01CA297224-01 grant, which explores mitochondrial dysfunction in hematological disorders, demonstrates recognition of their research’s potential impact on clinical outcomes in cancer treatment.

  6. Recognition in the Scientific Community: Their involvement in major conferences, such as the Beat AML symposium, and their collaborations with international experts further solidify their reputation in the field of oncological research.

Areas for Improvement:

  1. Broader International Collaboration: While Dr. Zhang has already made notable contributions within the U.S. and Europe, expanding collaborations with researchers in Asia and other parts of the world could enhance the global impact of their work and open up new avenues for interdisciplinary research.

  2. Involvement in Clinical Trials: Although Dr. Zhang’s work is highly relevant to clinical outcomes, increasing involvement in clinical trial design or translation of findings into clinical settings could help bridge the gap between basic science and patient care. This would also make their research directly applicable to the next generation of therapeutic interventions.

  3. Public Outreach and Education: Dr. Zhang could consider increasing their involvement in public outreach, particularly in educating patients and communities about the implications of their research. Such initiatives could contribute to greater awareness and understanding of the role of genomics in cancer treatment.

Education:

Haijiao Zhang’s academic journey began with a Bachelor of Medicine (B. Med) from Jilin University (2005-2010). He then pursued a Master’s in Medicine (M. Med) at the First Hospital of Jilin University (2010-2012), before moving to Hannover Medical School in Germany, where he earned his Doctor of Medicine (M.D.) degree (2012-2015). Following his M.D., Zhang joined the prestigious Knight Cancer Institute at Oregon Health & Science University for postgraduate research (2015-2020). His work at the Knight Cancer Institute has been instrumental in his academic and professional growth, particularly in oncology research, where he focused on genetic mutations and drug resistance mechanisms in hematologic malignancies. With a strong foundation in clinical and experimental oncology, Zhang combines his medical training with cutting-edge research to advance cancer treatment strategies.

Experience:

Haijiao Zhang is currently an Assistant Professor at Oregon Health & Science University in the Division of Oncological Sciences, a position he has held since July 2021. Prior to his faculty appointment, he was a Postdoctoral Fellow at the same institution (2015–2020), where he worked under the mentorship of prominent researchers in cancer genomics. In the early years of his postdoc, Zhang identified novel mechanisms related to chronic neutrophilic leukemia (CNL) and CFS3R mutations. He has also collaborated on high-impact research regarding cancer drug resistance, focusing on therapeutic strategies for AML. His research interests primarily involve chromosome deletions, oncogenes, tumor suppressor genes, and the molecular mechanisms underlying cancer drug resistance. Zhang’s work has been widely published and is considered foundational in the field. His efforts aim to personalize cancer therapies by understanding genetic drivers of malignancies, ultimately improving patient outcomes.

Awards and Honors:

Haijiao Zhang has received numerous honors and awards for his academic and research achievements. Notably, in 2014, he earned the Best Abstract Award at the 21st Jahrestagung der Deutschen Gesellschaft für Immungenetik. In the same year, he received a Travel Grant for the 47th Annual Meeting of the German Society for Transfusion Medicine and Immunohematology. Zhang’s early academic accomplishments were recognized with a range of awards, including a Travel Grant in 2012 and accolades in 2009 and 2008. His commitment to advancing cancer research has not only led to multiple successful grant applications but has also made him a sought-after speaker at major scientific conferences. His contributions have been instrumental in improving the understanding of drug resistance in leukemia, earning him recognition from peers and institutions alike. Zhang’s expertise continues to shape the field of hematology and oncology, inspiring future breakthroughs in cancer treatment.

Research Focus:

Haijiao Zhang’s research primarily focuses on understanding the genetic and molecular mechanisms behind hematologic cancers, particularly leukemia. His work investigates chromosome abnormalities, such as copy number deletions, and their role in cancer progression. He has contributed significantly to understanding drug resistance mechanisms, particularly in acute myeloid leukemia (AML) and chronic neutrophilic leukemia (CNL). Zhang is particularly interested in targeting mitochondrial dysfunction as a potential therapeutic strategy for hematological disorders, as seen in his work on -7del(7q) mutations. His research aims to identify new biomarkers for cancer prognosis and treatment responses. By analyzing drug resistance and genomic landscapes, Zhang strives to personalize cancer treatments and improve patient outcomes. His innovative approach combines molecular genetics, drug discovery, and cancer biology, pushing the boundaries of precision medicine. Zhang’s ongoing research promises to offer novel therapeutic targets and strategies for overcoming current treatment limitations in blood cancers.

Publications Top Notes:

  1. A CEBPB/IL-1β/TNF-α Feedback Loop Drives Drug Resistance to Venetoclax and MDM2 Inhibitors in Monocytic Leukemia 🩸
  2. Upregulation of HOXA3 by Isoform-Specific Wilms Tumor 1 Drives Chemotherapy Resistance in Acute Myeloid Leukemia 💉
  3. CDK12/13 Dual Inhibitors Are Potential Therapeutics for Acute Myeloid Leukemia 🧬
  4. Integrative Analysis of Drug Response and Clinical Outcome in Acute Myeloid Leukemia 🔬
  5. Activation of RAS/MAPK Pathway Confers MCL-1 Mediated Acquired Resistance to BCL-2 Inhibitor Venetoclax in Acute Myeloid Leukemia 💊
  6. Biomarkers Predicting Venetoclax Efficacy and Venetoclax Combination Strategies 🔬
  7. Genomic Landscape of Neutrophilic Leukemias of Ambiguous Diagnosis 🧬
  8. Clinical Resistance to Crenolanib in Acute Myeloid Leukemia Due to Diverse Molecular Mechanisms 💉
  9. Two Myeloid Leukemia Cases with Rare FLT3 Fusions 🧬
  10. Functional Genomic Landscape of Acute Myeloid Leukemia 🔬

Conclusion:

Dr. Haijiao Zhang is highly deserving of the Best Researcher Award due to their groundbreaking contributions to cancer research, particularly in understanding the molecular mechanisms of drug resistance in leukemia. Their ability to conduct impactful research, secure prestigious funding, and consistently publish in top-tier journals underscores their commitment to advancing the field of oncological sciences. While there is room for growth in clinical trial involvement and international collaboration, Dr. Zhang’s ongoing research promises to shape future cancer therapies and improve patient outcomes.

 

 

 

Dana Hassouneh | Microbial Cell Biology | Best Researcher Award

Published on by Cell Biologist

Dr. Dana Hassouneh | Microbial Cell Biology | Best Researcher Award

Dr. Dana Hassouneh , King Hussein Cancer Center , Jordan

Dana Hassouneh is a dedicated Clinical Pharmacist from Amman, Jordan, with extensive experience working in hospitals, clinics, and community pharmacies. Passionate about patient-centered care, Dana is committed to enhancing medication therapies while continuously expanding her medical knowledge. Dana’s professional expertise includes inpatient pharmacy, chemotherapy, patient counseling, and drug interactions. As a co-investigator in research, she is also deeply involved in improving healthcare outcomes, particularly in oncology. Dana’s strong communication, organizational, and counseling skills have made her a valuable asset in the healthcare field. She is an advocate for educating patients and healthcare professionals to ensure proper medication use and adherence to prescribed therapies.

Publication Profile: 

Orcid

Strengths for the Award 💪

Dana Hassouneh exhibits a strong commitment to patient-centered care and advanced research in the field of clinical pharmacy, particularly in oncology and infectious diseases. Her contributions as a co-investigator in high-impact research, such as the study on microbiological profiles and resistance patterns in pediatric cancer patients, reflect her deep analytical skills and her dedication to improving patient outcomes. Dana’s ability to bridge the gap between clinical practice and research is a standout feature, making her an invaluable asset to the medical community. Her research at the King Hussein Cancer Center, which includes investigating community-acquired pneumonia in cancer patients, demonstrates her ability to approach complex medical problems with a scientific mindset and her willingness to engage in meaningful work to advance healthcare.

Areas for Improvements 🌱

While Dana’s expertise is remarkable, there is always room to expand her research focus and broaden her collaborative network. Increasing her involvement in multi-center, international research collaborations could offer her exposure to a wider variety of data and perspectives, further strengthening her research abilities. Moreover, refining advanced statistical analysis skills and gaining additional training in emerging research methodologies could contribute to more robust and innovative findings. Dana could also consider focusing on improving interdisciplinary collaborations, especially between clinical pharmacy, microbiology, and oncology to enhance her ability to address multifaceted medical challenges.

Education 🎓

Dana graduated from the University of Jordan with a Clinical Pharmacist degree in 2021, achieving an impressive 3.69/4 GPA. Prior to this, she completed her IGCSE studies at Global International School, where she earned a remarkable score of 97.6/100. Throughout her academic journey, Dana has demonstrated exceptional skills in pharmacology and therapeutic practices, laying the foundation for her successful career as a clinical pharmacist. Her education has enabled her to integrate evidence-based medicine into her practice while developing the skills necessary for medication therapy management and patient education. Dana’s academic excellence continues to influence her ongoing professional growth, furthering her ability to contribute to the medical field and improve patient outcomes.

Experience 💼

Dana’s career began at Luqman Al-Hakeem Pharmacy, where she gained valuable patient interaction skills while dispensing medications and offering counseling. Later, as a clinical pharmacist at the King Hussein Cancer Center, Dana worked both in inpatient and chemotherapy pharmacies, ensuring safe medication therapy for cancer patients. Her role involved educating healthcare professionals about drug interactions and alternative therapies. Dana’s research experience as a co-investigator has also been significant, analyzing patient outcomes for those with community-acquired pneumonia. She has also trained at various healthcare settings such as Jordan University Hospital and Jordanian Royal Medical Services, enhancing her knowledge of patient medication management and adherence. This diverse experience has honed Dana’s clinical expertise and strengthened her passion for improving patient care and outcomes.

Research Focus 🔬

Dana’s research primarily focuses on improving patient outcomes through medication therapy management and investigating disease-specific therapies. Her recent work as a co-investigator at King Hussein Cancer Center involves studying the characteristics and outcomes of patients with community-acquired pneumonia. Dana is deeply engaged in the process of manuscript writing and data analysis, with a focus on oncology and infectious diseases. She has also contributed to research regarding microbiological profiles and resistance patterns in pediatric cancer patients. Her research aims to provide evidence-based solutions that can enhance treatment protocols, reduce medication errors, and optimize healthcare delivery for cancer patients. Dana’s work contributes to bridging the gap between clinical practice and research, ensuring that patients receive the best possible care based on up-to-date scientific evidence.

Publications Top Notes 📚

Microbiological Profiles and Resistance Patterns in Pediatrics With Cancer: An 8‐Year Study at a Comprehensive Cancer Center in Jordan – Cancer Reports (2025-03)

Conclusion 🎯

Dana Hassouneh’s blend of clinical practice and research expertise makes her an excellent candidate for the Research for Best Researcher Award. Her strengths in patient education, counseling, and collaboration with multidisciplinary teams position her as an emerging leader in the field. As she continues to develop her research focus and expands her skill set, Dana is poised to contribute significantly to advancements in clinical pharmacy and oncology research. Her passion, diligence, and commitment to improving patient care are undeniable, making her a valuable asset to the healthcare field.

Ranran Li | Signal Transduction Mechanisms | Best Researcher Award

Published on by Cell Biologist

Dr. Ranran Li | Signal Transduction Mechanisms | Best Researcher Award

Ranran Li , Ruijin Hospital, Shanghai Jiao Tong University School of Medicine , China

Dr. Ranran Li is an associate researcher at Ruijin Hospital, Shanghai Jiao Tong University School of Medicine in Shanghai, China. She earned her Ph.D. from the University Medical Center of Groningen, Netherlands, in 2015, before returning to Shanghai to focus on critical care medicine. Her research centers on sepsis-associated endothelial dysfunction and its underlying molecular mechanisms. Over the years, Dr. Li’s work has provided valuable insights into the role of metabolic disorders and post-translational modifications in regulating endothelial inflammation and coagulation during sepsis. She has published extensively in reputable journals and holds several patents. Her recent findings suggest potential therapeutic targets for the treatment of sepsis and related complications, including endothelial dysfunction and organ injury.

Publication Profile:

Scopus

Strengths for the Award:

Dr. Ranran Li is a distinguished researcher with notable expertise in the mechanisms of sepsis-associated endothelial dysfunction. Her work in identifying the role of metabolic disorders and post-translational modifications in sepsis has been pivotal in advancing the understanding of vascular inflammation and coagulation during critical illness. Her research has led to several high-impact publications and patents, showcasing her contributions to the field. Furthermore, Dr. Li’s interdisciplinary approach, combining metabolic biology, cell signaling, and translational medicine, has provided valuable therapeutic targets for the treatment of sepsis and endothelial dysfunction. Her collaborations with international experts enhance her work’s impact and broaden the scope of her research.

Areas for Improvements:

While Dr. Li’s research has been extensive and groundbreaking, future improvements could include increased collaborations with industry partners to accelerate the translation of her findings into clinical therapies. Expanding her professional network through international collaborations in other areas of critical care medicine could also provide new perspectives and avenues for innovation. Additionally, engaging in larger-scale clinical studies might help further validate her findings in human models.

Education

Dr. Ranran Li obtained her Ph.D. in Medical Sciences from the University Medical Center of Groningen, Netherlands, from 2011 to 2015. During her doctoral studies, she focused on the molecular mechanisms of sepsis and its impact on vascular endothelial dysfunction. Her Ph.D. research laid the foundation for her ongoing investigations into the pathophysiology of sepsis and endothelial injury. Following her Ph.D., she joined Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, in 2016 as an associate researcher in the Department of Critical Care Medicine. Here, Dr. Li furthered her research into sepsis, vascular inflammation, and metabolic disorders. She has developed an expertise in endothelial dysfunction and coagulation, specifically in the context of sepsis-induced organ injuries. Dr. Li’s comprehensive academic training, both in Europe and China, has significantly contributed to her innovative research work and international collaborations.

Experience:

Dr. Ranran Li has been serving as an associate researcher at Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, since 2016. Prior to this, she earned her Ph.D. from the University Medical Center of Groningen in the Netherlands, where she focused on sepsis and endothelial dysfunction. In her current position, Dr. Li has worked extensively on understanding the mechanisms underlying sepsis-associated endothelial dysfunction, with a particular focus on metabolic disorders and post-translational modifications. Her work has provided critical insights into the role of fatty acid metabolism, insulin resistance, and histone modifications in regulating endothelial inflammation and coagulation activation in sepsis. Dr. Li’s research has led to multiple publications in high-impact journals and the filing of patents for innovative therapeutic approaches. She collaborates with leading researchers in the Netherlands and has contributed significantly to the understanding of vascular injury and its therapeutic targets in sepsis.

Research Focus:

Dr. Ranran Li’s research focuses on the molecular mechanisms of sepsis-associated endothelial dysfunction, with a particular emphasis on metabolic disorders and post-translational modifications. She has been exploring how fatty acid metabolism, glucose-lipid metabolism, and protein acetylation influence endothelial cells during sepsis, leading to organ injury. Her research has highlighted the role of metabolic shifts, including the activation of pathways like AMPK/PKA, in endothelial inflammation and coagulation activation. Dr. Li has also studied the role of histone modifications, including lactylation, in promoting endothelial ferroptosis and dysfunction during sepsis-induced lung injury. She has been pioneering the exploration of metabolic signaling pathways and their potential as therapeutic targets for managing sepsis-related endothelial damage. Her work aims to identify novel strategies to prevent or mitigate vascular injury in septic patients. Dr. Li’s findings have led to both patents and high-impact publications in critical care and translational medicine.

Publications Top Notes:

  1. Shiyuan He et al., Fatty acid synthesis promotes mtDNA release via ETS1-mediated oligomerization of VDAC1 facilitating endothelial dysfunction in sepsis-induced lung injury 🧬🫁 Cell Death and Differentiation, 2025
  2. Ranran Li et al., ATP-citrate lyase controls endothelial gluco-lipogenic metabolism and vascular inflammation in sepsis-associated organ injury 💉🧪 Cell Death and Disease, 2023
  3. Jie Liu et al., Designed microchannel-based lipid nanoparticles encapsulated siRNA targeting gasdermin D for sepsis management via pulmonary delivery 🧬💉 Nano Today, 2025
  4. Fangchen Gong et al., H3K14la drives endothelial dysfunction in sepsis-induced ARDS by promoting SLC40A1/transferrin-mediated ferroptosis 🧬🔥 MedComm, 2025
  5. Jiayin Cui et al., Herbal-based Xuebijing injection ameliorated vascular endothelial dysfunction via inhibiting ACLY/MYB/RIG-I axis in sepsis-associated lung injury 🌱💊 Phytomedicine, 2025
  6. Shasha Lu et al., GDF15 ameliorates sepsis-induced lung injury via AMPK-mediated inhibition of glycolysis in alveolar macrophage 💨🧪 Respiratory Research, 2024
  7. Rui Tian et al., Shenfu injection ameliorates endotoxemia-associated endothelial dysfunction and organ injury via inhibiting PI3K/Akt-mediated glycolysis 💉🫀 Journal of Ethnopharmacology, 2024
  8. Yupeng Zhao et al., H3K18 lactylation-mediated VCAM1 expression promotes gastric cancer progression and metastasis via AKT-mTOR-CXCL1 axis 🎗️🧬 Biochemical Pharmacology, 2024
  9. Rui Tian et al., Metformin ameliorates endotoxemia-induced endothelial pro-inflammatory responses via AMPK-dependent mediation of HDAC5 and KLF2 💊💉 BBA-Molecular basis of disease, 2019
  10. Lei Pei et al., MSCs-derived extracellular vesicles alleviate sepsis-associated liver dysfunction by inhibiting macrophage glycolysis-mediated inflammatory response 🧬🩸 International Immunopharmacology, 2024

Conclusion:

Dr. Ranran Li is highly deserving of the Best Researcher Award due to her outstanding contributions to understanding the molecular mechanisms underlying sepsis-related endothelial dysfunction. Her innovative research has not only provided deep insights into the pathophysiology of sepsis but has also uncovered potential therapeutic targets for treating this devastating condition. Her exceptional track record of high-quality publications, patents, and collaborative research, combined with her dedication to advancing critical care medicine, makes her an excellent candidate for this prestigious award.

ASEM SANJIT SINGH | Developmental Cell Biology | Young Scientist Award

Published on by Cell Biologist

Dr. ASEM SANJIT SINGH | Developmental Cell Biology | Young Scientist Award

Dr. ASEM SANJIT SINGH , INDIAN INSTITUTE OF SCIENCE, BANGALORE , India

r. Asem Sanjit Singh is a distinguished DBT-Post-Doctoral Research Associate at the Indian Institute of Science, Bangalore. He holds a Ph.D. in Post-Harvest Technology (Microbiology) from ICAR-CIFE and is currently exploring the gut microbiota and host interactions in his post-doctoral research. Dr. Singh has an extensive academic background, having received prestigious awards such as the Dr. C.V. Kulkarni Gold Medal for best M.F.Sc. research (2014-2015) and the Young Scientist Award (2025) from GRIAST. His work in microbiology, particularly in antibiotic resistance in seafood, has gained significant recognition in the scientific community. Dr. Singh has a proven track record of contributing valuable research, with multiple publications in top-tier journals.

Publication Profile: 

Google Scholar

Strengths for the Award:

  1. Educational Background & Expertise:

    • Dr. Asem Sanjit Singh has a solid educational foundation, with degrees in Fisheries Science and Post-Harvest Technology (Microbiology), from reputable institutions such as ICAR-CIFE and the Indian Institute of Science (IISc).
    • His ongoing postdoctoral research on gut microbiomes and host crosstalk, with a focus on the effects of antibiotics, aligns with contemporary concerns in microbiology and environmental health.

  2. Recognized Research Contributions:

    • Dr. Singh has an impressive track record of publications in high-impact journals, including J. Microbiology, Environmental Science & Pollution Research, and International Journal of Food Microbiology.
    • His research on multidrug-resistant bacteria in seafood and the characterization of virulent microorganisms from aquatic products has significantly advanced food safety and public health understanding.
    • His recent publications, such as on the impact of antibiotics on microbiomes and the potential toxicity of antibiotics in aquatic systems, reflect his cutting-edge research and interdisciplinary approach.

  3. Awards and Recognition:

    • The Dr. C.V. Kulkarni Gold Medal for Best M.F.Sc. Research (2014-2015) and his Young Scientist Award (2025) from GRIAST highlight his exceptional contributions to the field.
    • His ongoing DBT post-doctoral research fellowship and other prestigious awards underline the recognition he has received within the scientific community.

  4. Diverse Research Themes:

    • His research spans multiple relevant themes, including antimicrobial resistance (AMR), seafood safety, environmental health, and microbiome dynamics. These diverse topics are highly relevant to global health challenges, demonstrating his ability to tackle complex issues through multidisciplinary approaches.

  5. National and International Presentations:

    • Dr. Singh has presented his work at international seminars and conferences, further establishing his reputation as a promising young scientist. This shows his commitment to sharing knowledge and fostering collaboration with peers globally.

  6. Book Contributions & Popular Articles:

    • Dr. Singh has authored and co-authored several chapters and articles, further demonstrating his academic influence and his role as a thought leader in fisheries science and microbiology.

Areas for Improvement:

  1. Broader Public Engagement:

    • While his academic achievements are exemplary, Dr. Singh could benefit from engaging more directly with public education and outreach initiatives. This could help in translating his research findings into practical applications for society, particularly in food safety and public health.

  2. Collaborative Projects Across Disciplines:

    • As his research intersects several fields, further collaborations with public health, policy makers, and industries (like seafood and environmental conservation) could yield more real-world impacts. Developing such partnerships would help bridge the gap between academic findings and practical applications.

  3. Mentoring and Leadership:

    • Mentoring more students and young researchers could enhance his leadership profile. As he continues his post-doctoral work, taking on a larger mentoring role could cultivate the next generation of scientists in his area of expertise.

  4. Increased Focus on Translational Research:

    • Focusing more on translating his findings into actionable solutions for the seafood industry, such as developing methods for reducing antibiotic resistance or improving seafood safety standards, could increase the societal impact of his work.

Education:

Dr. Singh completed his schooling at CBSE, New Delhi, scoring well in both 10th (71.2%) and 12th (62.4%). He graduated with a B.F.Sc. in Fisheries Science from the College of Fisheries, CAU, Imphal (2012), securing an impressive 83.9%. He went on to pursue an M.F.Sc. in Post-Harvest Technology (Microbiology) at ICAR-CIFE, Mumbai, where he received the Dr. C.V. Kulkarni Gold Medal (2014) for his research excellence. His Ph.D. research focused on “Molecular mechanisms of antibiotic resistance-producing Escherichia coli associated with seafood,” achieving a first-class distinction with 86.2%. Dr. Singh is now a Post-Doctoral Research Associate at the Indian Institute of Science (IISc), Bangalore, where he is further enhancing his expertise in microbiology, focusing on gut microbes and host interactions.

Experience:

Dr. Singh’s research journey began with his B.F.Sc. and M.F.Sc., followed by a Ph.D. at ICAR-CIFE, where he focused on antibiotic resistance mechanisms in seafood. His doctoral thesis explored the molecular aspects of Escherichia coli’s resistance to antibiotics, contributing significantly to food safety and public health research. Since March 2021, he has been engaged in post-doctoral research at IISc, studying the trans-generational impact of antibiotic exposure using Drosophila melanogaster as a model organism. He has also held fellowships from ICAR and DBT, receiving the ICAR-Institute fellowship for both his postgraduate and doctoral studies. Dr. Singh has contributed to over 13 peer-reviewed publications, spanning diverse aspects of microbiology, including antibiotic resistance, gut microbiota, and environmental pressures. His professional experience and advanced research focus on solving critical issues related to food safety, microbiome interactions, and environmental sustainability in aquaculture.

Awards and Honors:

Dr. Asem Sanjit Singh has received several prestigious awards and honors for his exemplary contributions to microbiology and aquaculture research. In 2014, he was honored with the Dr. C.V. Kulkarni Gold Medal for best M.F.Sc. research. In 2015, his M.F.Sc. thesis was recognized as the Best Indian M.F.Sc. Thesis by PFGF. His groundbreaking work on seafood safety earned him the Young Scientist Award in 2025 from GRIAST. Dr. Singh’s academic achievements are further complemented by multiple fellowships, including the ICAR-Institute Fellowship for his postgraduate and doctoral studies. He is currently a DBT-Post-Doctoral Research Associate at IISc-Bangalore (2022-2025). These awards reflect his consistent academic excellence, research commitment, and significant contributions to microbiology, particularly in food safety, antibiotic resistance, and environmental sustainability.

Research Focus:

Dr. Asem Sanjit Singh’s research focuses on microbiology, particularly antibiotic resistance mechanisms in seafood, gut microbiota, and the trans-generational effects of antibiotics on model organisms. His post-doctoral research at the Indian Institute of Science, Bangalore, delves into the intricate interactions between gut microbes and their hosts. His work in seafood safety has revealed significant insights into antibiotic-resistant Escherichia coli and other pathogens, contributing to public health concerns related to foodborne diseases. Dr. Singh’s studies on the impact of antibiotics on microbiota and fertility in organisms like Drosophila melanogaster provide valuable data for understanding environmental and health implications. Additionally, his work on microplastics, pollution, and the sustainability of aquaculture systems highlights his commitment to improving the environmental and health aspects of fisheries. Dr. Singh’s research has profound implications for food safety, environmental sustainability, and microbial health.

Publications Top Notes:

  1. Isolation of Escherichia coli harboring blaNDM-5 from fresh fish in India 🐟🔬
  2. Evaluation of textural quality as a parameter to optimize thermal process during retort pouch processing of boneless rohu balls in curry medium 🍛🐟
  3. Multiple antibiotic-resistant, Extended Spectrum-β-Lactamase (ESBL)-producing enterobacteria in fresh seafood 🦠🐠
  4. Characterization of blaNDM-harboring, multidrug-resistant enterobacteriaceae isolated from seafood 🧫🌊
  5. Virulence genotypes and antimicrobial susceptibility patterns of Arcobacter butzleri isolated from seafood and its environment 🦠🌍
  6. Effects of rosemary extracts on textural and functional qualities of surimi gel from striped catfish 🐟🌿
  7. High prevalence of multiple antibiotic-resistant, Extended-Spectrum β-Lactamase (ESBL)-producing Escherichia coli in fresh seafood sold in retail markets of Mumbai 🛒🐟
  8. Quality assessment of fishes caught by single-day and multi-day gillnet fishing off Satpati coast, Maharashtra, India 🌊🎣
  9. Environmental pressure of active fishing method: a study on carbon emission by trawlers from northwest Indian coast 🚢🌍
  10. Characteristics and mechanism of potential probiotics with special reference to lactic acid bacteria from traditional fermented fish products 🦠🥘

Conclusion:

Dr. Asem Sanjit Singh is an exceptionally deserving candidate for the Young Scientist Award. His comprehensive research portfolio, coupled with his academic excellence, dedication to public health, and numerous recognitions, positions him as an emerging leader in microbiology, food safety, and environmental health. His work has already made significant contributions to the field of seafood safety and antibiotic resistance, and with further focus on public outreach and mentoring, he could amplify his impact. His ability to approach complex scientific issues from an interdisciplinary perspective makes him a standout candidate for the award.

Dia Aldeen Alfaki | Immunology Cellular Interactions | Best Researcher Award

Published on by Cell Biologist

Mr. Dia Aldeen Alfaki | Immunology Cellular Interactions | Best Researcher Award

Mr. Dia Aldeen Alfaki , Alzaiem Alazhari University , Sudan

Dia Alfaki is a Sudanese biomedical scientist with a Master of Biomedical Sciences and extensive experience in haematology, molecular biology, and immunology. His research focuses on the complexities of disease mechanisms and therapeutic solutions, particularly within immunology. As a junior researcher and PG Member of the British Society of Immunology, Dia has contributed significantly to studies on malaria and immune responses. His academic background includes a Master’s degree from Alzaiem Alazhari University and a Bachelor’s degree from Omdurman Islamic University. Dia’s dedication to understanding disease complexities through research is reflected in his growing academic presence and expertise in clinical laboratory techniques. He is committed to advancing scientific knowledge and improving healthcare solutions through his research endeavors.

Publication Profile: 

Orcid

Strengths for the Award:

Dia Alfaki has a remarkable blend of educational qualifications, practical experience, and academic research, making him highly suitable for the Research for Best Researcher Award. His work spans critical areas in biomedical sciences, with a special focus on immunology, haematology, and molecular biology, especially in relation to infectious diseases like malaria. His Master’s research on immune responses to Plasmodium falciparum infection stands out, demonstrating his ability to identify novel immunological markers. His published work in well-regarded journals like Microbiologia Medica and Immunology & Cell Biology further showcases his expertise. He has actively contributed to the scientific community through various international conferences, highlighting his commitment to advancing research. His work at G42 Healthcare underscores his technical skills in molecular diagnostics and cutting-edge biomedical research. His collaborative nature, critical thinking, and proven leadership in research make him a strong contender for this award.

Areas for Improvement:

While Dia Alfaki has a solid foundation in immunology and biomedical research, further expansion of his research portfolio into diverse therapeutic fields could enhance his profile. Gaining more experience in clinical settings beyond molecular labs could provide him with a broader perspective in healthcare applications. Additionally, his involvement in multi-disciplinary research collaborations across diverse disease areas such as oncology and genomics would elevate his impact on global biomedical challenges. Developing greater expertise in bioinformatics tools and integrating them into his molecular research would further refine his analytical skills and position him as an even more influential scientist in his field.

Education:

Dia Alfaki holds a Master’s degree in Biomedical Sciences from Alzaiem Alazhari University (2014-2016), where he specialized in Medical Laboratory Sciences with a focus on Haematology and Blood Transfusion, achieving a CGPA of 3.19/4.0. He completed his Bachelor’s degree in Medical Laboratory Sciences from Omdurman Islamic University (2007-2011), where he excelled in Hematology and Immunohematology. Additionally, Dia is pursuing certification as an International Medical Lab Technologist in Hematology (ASCPi) from the American Society for Clinical Pathology (2022-2025). His academic and professional development demonstrates a strong foundation in biomedical sciences, preparing him to make significant contributions to immunology research and clinical diagnostics.

Experience:

Dia Alfaki has worked as a Molecular Lab Technologist at G42 Healthcare (Biogenix Molecular Labs) from 2020-2023, contributing to advanced molecular research and diagnostics. His expertise spans a wide range of laboratory techniques, particularly in immunology, molecular biology, and hematology. Throughout his career, Dia has been involved in various research projects, including his Master’s thesis focused on the immune response to Plasmodium falciparum infection. He has also contributed to several high-impact publications, collaborating with experts in the field of malaria, immune phagocytosis, and cancer immunology. His role in molecular diagnostics has allowed him to apply his research findings to real-world clinical settings, furthering the understanding of disease pathology and therapeutic interventions.

Awards and Honors:

Dia Alfaki has been recognized for his significant contributions to biomedical science, particularly in immunology research. He participated in prominent international conferences, including the 6th European Congress of Immunology (2022) and the American Association for Cancer Research Annual Meeting (2021). His ongoing work in malaria immunology and cancer immunology is highly regarded in scientific communities. As a PG Member of the British Society of Immunology since 2021, Dia continues to gain recognition for his research on immune responses and inflammation. His work has also been highlighted in various prestigious journals, where his research on malaria and immune responses has earned accolades. These honors reflect his commitment to advancing scientific knowledge and improving healthcare through rigorous research.

Research Focus:

Dia Alfaki’s research is primarily focused on immunity, inflammation, cancer immunology, and molecular oncology. His work emphasizes understanding disease mechanisms, particularly the immune responses involved in infections like malaria and the pathogenesis of diseases such as cancer. Dia is particularly interested in the role of immune mediators, phagocytosis, and molecular interactions in disease progression and therapy. His research aims to explore therapeutic perspectives in immunology, using molecular and cellular approaches to better understand disease complexities and improve treatment options. His publications highlight these areas, especially in the context of malaria and inflammatory immune responses. Dia is also committed to utilizing molecular techniques and bioinformatics tools to contribute to new therapeutic strategies for immunological diseases.

Publications Top Notes:

  1. Patterns of Mannose-Binding Lectin (MBL) responses to Plasmodium falciparum infections in hyperendemic settings 📚🔬
  2. Inflammatory immune mediators and Plasmodium falciparum infection: a cross-sectional study among Sudanese patients with severe and uncomplicated malaria 🌍🦠
  3. Monocytes to lymphocytes ratio in peripheral blood and immunoglobulin IgE levels as indicators to Plasmodium falciparum infection in Sudan 📖🔬
  4. The colorectal cancer microenvironment: Preclinical progress in identifying targets for cancer therapy 🦠🔬
  5. Plasmodium falciparum and immune phagocytosis: characterization of the process 🦠💉

Conclusion:

Dia Alfaki is an outstanding researcher with a well-rounded background in biomedical sciences, molecular biology, and immunology. His research accomplishments, publications, and contributions to international conferences highlight his drive for advancing scientific knowledge, particularly in the area of disease mechanisms and immune responses. His strong academic foundation, coupled with his practical lab experience and active engagement with the scientific community, positions him as an excellent candidate for the Research for Best Researcher Award. With a few areas of growth in clinical practice and cross-disciplinary collaborations, he has the potential to become a leader in global biomedical research.

Prahlad Singh | Developmental Cell Biology | Best Researcher Award

Published on by Cell Biologist

Prof. Prahlad Singh | Developmental Cell Biology | Best Researcher Award

Prof. Prahlad Singh , Guru Angad Dev Veterinary and Animal Sciences University , India

PRAHLAD SINGH is a distinguished scientist and academician with over 30 years of experience in veterinary science and animal husbandry. He currently serves as a Professor-cum-Nodal Officer at the MSVH&RRTC, Guru Angad Dev Veterinary and Animal Sciences University (GADVASU), Ludhiana. Prahlad’s expertise lies in veterinary gynecology and obstetrics, with significant contributions to reproductive health and cryobiology in livestock, particularly buffaloes. His academic journey has been complemented by his role as a leader in research programs and his involvement in international collaborations. Known for his leadership in managing major research and development projects, he also holds expertise in financial management, fiscal control, and strategic planning for research initiatives. Prahlad Singh’s commitment to education and research has been recognized in national and international circles, making him a key figure in veterinary sciences.

Publication Profile: 

Orcid

Strengths for the Award:

  1. Educational Background and Qualifications:

    • Prahlad Singh holds a Doctor of Philosophy (Ph.D.) in Veterinary Gynaecology and Obstetrics, a distinguished qualification in the field of Veterinary Science.
    • His career has been built on strong academic credentials, evidenced by his Bachelor’s in Veterinary Sciences and Animal Husbandry and Master’s in Veterinary Science (MVSc).

  2. Professional Experience:

    • He has more than 10 years of experience in a professor-cum-Nodal Officer role at the prestigious Guru Angad Dev Veterinary and Animal Sciences University in Punjab.
    • His involvement in high-level management and infrastructure development as a Nodal Officer demonstrates his leadership capabilities.
    • He has overseen major R&D programs with over 10 scientists under his leadership.

  3. Research Contributions and Publications:

    • Prahlad Singh’s research is highly impactful, with several quality publications in journals with NAAS ratings of 7.5 and above, including Cryobiology (NAAS rating 8.728), a highly regarded journal in the veterinary science community.
    • His work on cryoprotectants and sperm functionality in crossbred bulls and Murrah buffalo bulls is pioneering, contributing to the advancement of reproductive technologies in veterinary science.
    • The diversity in his research spans topics such as animal nutrition, fertility, cryobiology, and reproductive health, showcasing a broad, impactful influence on his field.
    • His contributions have been internationally recognized, with his research presented at global conferences like CRYO2022.

  4. International Exposure and Leadership in Training:

    • Singh has completed international training programs, such as at The Koret School of Veterinary Medicine in Israel, demonstrating a global perspective in his approach to veterinary sciences.
    • His leadership in organizing national and international collaborative programs for Krishi Vigyan Kendras further enhances his profile as a well-rounded academician.

  5. Impact on the Veterinary Field:

    • His work has far-reaching implications for improving livestock health, especially in fertility enhancement and nutrition for buffaloes and other livestock.
    • His role in enhancing fertility strategies and advancing reproductive practices has directly impacted small-holder dairy farmers in Punjab.

Areas for Improvement:

  1. Broader Outreach and Collaboration:

    • Although Prahlad Singh has extensive experience in national and international collaborations, his work could benefit from broader inter-disciplinary collaborations, particularly in fields that intersect with agriculture, environmental sciences, and sustainable farming practices.
    • Further expanding his research scope beyond reproductive health into other areas of livestock management and animal welfare could amplify his contributions to the global scientific community.

  2. Public Communication:

    • While Singh’s research has been highly successful in journals and conferences, increasing his presence in popular science and policy-level discussions could make his work more accessible to a larger audience, including policymakers and farmers.

  3. Grant Acquisition and Resource Management:

    • Though he has experience in financial management, his ability to manage large-scale funding and grant acquisition could be emphasized further. Stronger grant management skills will help in securing resources for larger collaborative projects.

Education:

PRAHLAD SINGH holds a Ph.D. in Veterinary Gynecology and Obstetrics from Punjab Agricultural University, Ludhiana, Punjab. He completed his Master’s degree (MVSc) in Veterinary Science, with a focus on reproductive health, at the same university. His academic career began with a Bachelor of Veterinary Science and Animal Husbandry (B.V.Sc. & A.H.) from SKUAST, Srinagar, and continued at HPKV, Palampur. His educational journey is marked by an impressive blend of rigorous research and practical application, particularly in veterinary science disciplines related to animal reproduction and cryobiology. Prahlad’s education, paired with numerous advanced training programs, including an international course at the Hebrew University of Jerusalem, has equipped him with both the theoretical and practical knowledge to contribute significantly to the academic and scientific community.

Experience:

With over 30 years of experience in the field of veterinary science, PRAHLAD SINGH has held several prominent academic and administrative positions. Currently, he serves as a Professor-cum-Nodal Officer at the MSVH&RRTC, GADVASU, Ludhiana, where he is responsible for managing major research projects and overseeing infrastructure development. Prahlad has also held leadership roles as Associate Director (Training)-cum-Programme Coordinator, where he supervised financial planning, resource management, and collaborated with national and international institutions. He has vast experience in veterinary research, specializing in reproductive health, cryobiology, and veterinary gynecology, and has led several interdisciplinary research teams. Prahlad’s extensive experience in teaching, research, and management has earned him recognition both within India and internationally. His ability to balance scientific research with strategic management has made him a leading figure in his field.

Awards and Honors:

PRAHLAD SINGH has been recognized for his significant contributions to veterinary science and research. He has received accolades for his leadership in establishing research centers and managing large-scale scientific programs. Prahlad has been honored for his role in developing national and international collaborations, particularly in cryobiology and reproductive health in livestock. He has also been recognized for his ability to secure funding and manage financial resources for research initiatives. His work has earned him a place at major international conferences and research symposia. Prahlad’s extensive publication record in high-impact journals, coupled with his work on innovative techniques in veterinary medicine, has solidified his status as an eminent scientist. His dedication to advancing veterinary science and mentoring the next generation of researchers has earned him numerous honors in recognition of his academic and research excellence.

Research Focus:

PRAHLAD SINGH’s research primarily focuses on reproductive health, cryobiology, and the application of advanced techniques in veterinary gynecology and obstetrics. His work on cryopreservation and the effect of cryoprotectants on sperm functional and kinetic parameters in buffaloes has contributed significantly to improving livestock breeding practices. Prahlad is also focused on understanding and enhancing fertility in livestock, especially in cattle and buffaloes, through innovative approaches to hormonal synchronization and artificial insemination. Additionally, his research includes the development of new methodologies for improving the quality of semen for artificial breeding. Prahlad is particularly interested in exploring the impacts of dietary supplements and other factors on metabolic and reproductive health. His expertise in the field of veterinary science makes him a valuable asset in the areas of animal husbandry, reproductive health, and the application of modern biotechnology in animal breeding.

Publications Top Notes:

  • Harneet Kour, Ravinder Singh Grewal, Prahlad Singh, Jaspal Singh Lamba, Jasmine Kaur, Shashi Nayyar (2023) – Influence of Dietary Cation-Anion Differences (DCAD) on Nutrient Intake, Milk Yield and Metabolic Parameters of Transition Buffaloes 🐃📄
  • Prahlad Singh, Munish Kumar Bedi, Sumit Singhal, Ashwani Kumar Singh, Ajeet Kumar, Mrigank Honparkhe (2022) – Effect of graphene oxide as cryoprotectant on post-thaw sperm functional and kinetic parameters of cross bred (HF X Sahiwal) and Murrah buffalo bulls 🧪🔬
  • Prahlad Singh, Deepak Sharma, Sumit Singhal, Ajeet Kumar, Ashwani Kumar Singh, Mrigank Honparkhe (2022) – Sodium Dodecyl Sulphate, N-Octyl β-D Glucopyranoside and 4-Methoxy Phenyl β-D Glucopyranoside effect on post-thaw sperm motion and viability traits of Murrah buffalo bulls 🧊💉
  • Rajvinder Grover, Narinder Singh, Shahbaz Singh Dhindsa, Prahlad Singh, VS Malik (2022) – Effect of propofol vs ketofol on cardiorespiratory functions during ovariohysterectomy in healthy dogs 🐕🩺
  • Gulia N, Honparkhe M, Bisla A, Singh AK and Singh P (2022) – Intrauterine proteolytic enzymes therapy hastens expulsion of fetal membranes in dystocia affected buffaloes 🐃💉
  • Prahlad Singh, Munish Kumar Bedi, Sumit Singhal, Ashwani Kumar Singh, Ajeet Kumar, Mrigank Honparkhe (2022) – Effect of graphene oxide as cryoprotectant on post-thaw sperm functional and kinetic parameters of cross bred (HF X Sahiwal) and Murrah buffalo bulls 🧊💡
  • Ankit Kumar Ahuja, Deepak Sharma, Arundeep Singh, Nitin Dev Singh and Prahlad Singh (2022) – Arterial thrombosis and fibrinoid necrosis-possible etiology behind hydroallantois in Bubalus bubalis (water buffalo) 🐃⚡
  • US Khinda, SS Dhindsa, M Honparkhe, VS Malik and Prahlad Singh (2021) – Relationship between Estrus expression and fertility in Sahiwal cattle following modified timed artificial insemination protocols 🐄🌾
  • A K Singh, U Singh, A Sharma, P Kaur and Prahlad Singh (2021) – Effect of flaxseed supplementation on metabolic profile and reproductive performance of prepubertal gilts 🐖🥇
  • SS Dhindsa, SS Sodhi, Bilawal Singh and Prahlad Singh (2021) – Constraints faced by small holder dairy farmers in Ludhiana district of Punjab 🐄💼

Conclusion:

Prahlad Singh is a highly qualified and experienced researcher with a distinguished career in Veterinary Science. His academic achievements, combined with over a decade of professional experience, make him an outstanding candidate for the Best Researcher Award. His commitment to advancing research in veterinary science, specifically in fertility, cryobiology, and animal husbandry, sets him apart as an eminent scientist.

His leadership in developing national and international collaborations and contributions to livestock health management underscore his value in the field. Further improvements can be made by expanding his collaborations into other areas of agriculture and increasing his outreach to a broader audience.

Based on these strengths, Prahlad Singh is not only suitable for the Best Researcher Award, but he also demonstrates the qualities of an innovative leader who continues to contribute significantly to veterinary and animal sciences.

Ying Ren | Stem Cell Research | Best Researcher Award

Published on by Cell Biologist

Mrs. Ying Ren | Stem Cell Research | Best Researcher Award

Mrs. Ying Ren , Xuzhou Medical University , China

Ying Ren, a 32-year-old researcher from Xuzhou, Jiangsu province, China, is an accomplished scholar specializing in biomedical engineering. After completing her PhD at Peking Union Medical College, Tsinghua University Health Science Center (2015-2021), she is currently serving as a lecturer at the School of Stomatology, Xuzhou Medical University. Ren’s research journey is centered on bone marrow stem cells and their differentiation into odontogenic and osteogenic lineages. She is also deeply involved in exploring the synthesis and design of natural bioactive hydrogels aimed at enhancing bone tissue regeneration. Throughout her career, Ren has contributed to numerous impactful publications, demonstrating her expertise in the development of materials and techniques that support regenerative medicine.

Publication Profile: 

Scopus

Strengths for the Award:

Ying Ren’s academic and research profile positions her as a leading candidate for the Best Researcher Award in the field of biomedical engineering and tissue regeneration. Her research is highly innovative, with a focus on bone marrow stem cell differentiation and bioactive hydrogels designed to promote bone tissue regeneration. Ren’s ability to integrate molecular biology with material science is a key strength that is reflected in her numerous impactful publications. Her work in hydrogel design and stem cell culture systems stands out as cutting-edge, with clear implications for regenerative medicine and tissue engineering. The significant impact of her research is shown by her consistent publication in top-tier journals such as ACS Applied Bio Materials, Journal of Biomedical Nanotechnology, and Biomaterials. Moreover, her academic leadership as a lecturer at Xuzhou Medical University further demonstrates her capacity to contribute to both the scientific community and the education of future researchers.

Areas for Improvement:

While Ren’s research is highly promising, there is potential for expanding her focus to explore the clinical applications and translational aspects of her work more thoroughly. Moving beyond the lab and advancing her bioactive hydrogels and stem cell differentiation strategies toward clinical trials could greatly enhance the practical impact of her research. Additionally, while Ren has been successful in her publications, future collaborations with interdisciplinary researchers in the fields of clinical medicine and industry could help further elevate her work to new applications in regenerative therapies.

Education:

Ying Ren’s academic journey began with her Bachelor’s degree in Pharmacy from Tianjin Medical University (2011-2015), where she laid the foundation for her deep interest in biomedical sciences. She went on to pursue her PhD in Biomedical Engineering at Peking Union Medical College, Tsinghua University Health Science Center (2015-2021). Here, she focused on stem cell biology, particularly the odontogenic and osteogenic differentiation of bone marrow stem cells. Ren’s advanced research training equipped her with a solid understanding of the molecular mechanisms involved in tissue regeneration and the bioengineering of materials to promote this process. Her education has allowed her to merge the fields of pharmacy, biomedical engineering, and material science, which has been pivotal in shaping her current research direction. She has since become a well-respected academic, contributing valuable knowledge to the field of tissue engineering and regenerative medicine.

Experience:

Since August 2021, Ying Ren has been serving as a lecturer at the School of Stomatology, Xuzhou Medical University, where she continues to advance her research and teach the next generation of biomedical engineers. Before her current position, Ren had extensive academic exposure during her PhD, where she collaborated on various multidisciplinary projects that bridged the fields of stem cell biology, bioengineering, and material science. In her role as a lecturer, she not only teaches but also leads cutting-edge research in the development of natural bioactive hydrogels and their application in bone tissue regeneration. Her work is highly regarded in the academic community, and she has published several influential papers in top-tier journals. Ren’s research continues to focus on improving therapeutic outcomes for regenerative medicine, particularly through her exploration of bioactive materials designed for bone regeneration and cartilage repair.

Research Focus:

Ying Ren’s research is primarily focused on the differentiation of bone marrow-derived stem cells into odontogenic and osteogenic lineages, a key area for advancing bone tissue regeneration. She investigates the molecular and biomechanical mechanisms that regulate stem cell behavior and tissue formation. Her work emphasizes the design and synthesis of bioactive hydrogels, including collagen mimetic peptides and hyaluronic acid derivatives, to create environments that promote stem cell differentiation and tissue healing. In particular, Ren is dedicated to developing hydrogels with adjustable mechanical properties, facilitating controlled cell growth and tissue regeneration. Her innovative approach holds great promise for enhancing the repair of bone and cartilage defects. Moreover, Ren is exploring how different hydrogel stiffness and molecular structures influence stem cell fate, aiming to optimize these materials for clinical applications in regenerative medicine. Her research bridges fundamental biology with advanced materials science to address unmet medical needs in tissue engineering.

Publications Top Notes:

  1. Hyaluronic acid hydrogel with adjustable stiffness for mesenchymal stem cell 3D culture 🧬🦠, ACS Applied Bio Materials, 2021
  2. A gelatin-hyaluronic acid double cross-linked hydrogel for regulating the growth and dual dimensional cartilage differentiation of bone marrow mesenchymal stem cells 🧫💡, Journal of Biomedical Nanotechnology, 2021
  3. Locally delivered modified citrus pectin-a galectin-3 inhibitor shows expected anti-inflammatory and unexpected regeneration-promoting effects on repair of articular cartilage defect 🍊🦵, Biomaterials, 2022
  4. The effects of stiffness on the specificity and avidity of antibody-coated microcapsules with target cells are strongly shape dependent 🧪🔬, Colloids and Surfaces B: Biointerfaces, 2024
  5. A collagen mimetic peptide-modified hyaluronic acid hydrogel system with enzymatically mediated degradation for mesenchymal stem cell differentiation 🧬🛠, Materials Science & Engineering C, 2020

Conclusion:

Ying Ren’s innovative contributions to the fields of stem cell biology, bioengineering, and regenerative medicine make her a highly deserving candidate for the Best Researcher Award. Her work has the potential to advance medical treatments for bone and cartilage regeneration, a critical area in tissue engineering. With her proven track record, expertise, and dedication, Ren is well-positioned to continue leading groundbreaking research and making significant strides in the medical field.

Jung Ho Hyun | Neuronal Cell Biology | Best Researcher Award

Published on by Cell Biologist

Dr. Jung Ho Hyun | Neuronal Cell Biology | Best Researcher Award

Dr. Jung Ho Hyun , Daegu Gyeongbuk Institute of Science & Technology (DGIST) , South Korea

Dr. Jung Ho Hyun is an Assistant Professor at the Department of Brain Sciences, Daegu Gyeongbuk Institute of Science and Technology (DGIST), Korea. His research focuses on neurophysiology, cognitive neuroscience, and molecular tools for studying neural activity. He earned his Ph.D. in Physiology from Seoul National University (SNU) in 2015, after completing a Master’s in the same field at SNU. Dr. Hyun’s academic career includes significant research experience at prestigious institutions, including Johns Hopkins University and the Max Planck Florida Institute for Neuroscience. His work has led to important insights into memory, cognitive flexibility, and neuronal activity. Dr. Hyun is dedicated to mentoring young scientists and sharing his knowledge through invited lectures worldwide. His contributions to neuroscience have made a significant impact, evidenced by numerous publications in renowned journals.

Publication Profile: 

Google Scholar

Strengths for the Award:

Dr. Jung Ho Hyun is a highly accomplished and innovative researcher with significant contributions to the field of neuroscience, particularly in understanding neuronal activity and cognitive processes. His research focuses on cutting-edge topics such as memory, cognitive flexibility, and the development of molecular tools for neuronal manipulation. His ability to integrate molecular biology with neurophysiology has advanced the scientific community’s understanding of brain function, making his work highly relevant for both basic science and clinical applications. Dr. Hyun’s leadership and mentoring roles have also fostered future generations of neuroscientists, further solidifying his impact in the field.

Notable accomplishments include several prestigious awards and travel grants, invited lectures at international conferences, and a strong publication record in high-impact journals such as Nature Communications and The Journal of Physiology. His involvement in interdisciplinary research and development of novel techniques for manipulating neural circuits positions him as a leading figure in his field.

Areas for Improvement:

While Dr. Hyun has demonstrated tremendous research capabilities, one area for growth could be expanding his research collaborations to interdisciplinary fields such as computational neuroscience, which may further enhance the translation of his findings to clinical and therapeutic applications. In addition, as his work continues to gain prominence, a greater focus on the application of his research to the treatment of neurological diseases could increase the broader societal impact of his work.

Education:

Dr. Jung Ho Hyun completed his Bachelor’s degree in Biology from Pusan National University, South Korea, in 2007. He then pursued graduate studies at Seoul National University (SNU) College of Medicine, earning his Master of Science (M.Sc.) in Physiology in 2010. Following this, he continued his research journey and obtained a Ph.D. in Physiology from SNU in 2015 under the supervision of Dr. Suk-Ho Lee. Dr. Hyun’s strong academic foundation provided him with the tools to delve deeply into neurophysiology and molecular neuroscience. His educational journey has led to groundbreaking research at the intersection of memory, neuronal activity, and cognitive behavior. He has continuously built on his academic foundation with collaborative research experiences at leading global institutions such as Johns Hopkins University and the Max Planck Florida Institute for Neuroscience.

Experience:

Dr. Jung Ho Hyun currently serves as an Assistant Professor at the Department of Brain Sciences at Daegu Gyeongbuk Institute of Science and Technology (DGIST), South Korea. Prior to this, he was a JHU Research Fellow at Johns Hopkins University School of Medicine, where he contributed to important projects on cognitive neuroscience and neuronal activity. Dr. Hyun has also been involved in significant research activities at the Max Planck Florida Institute for Neuroscience. His primary research focus includes molecular tools for recording and manipulating neuronal activity, and understanding the molecular underpinnings of cognitive flexibility. In his academic career, he has not only contributed to cutting-edge research but has also been an educator, lecturing on human physiology and neuroimaging techniques. As a mentor, Dr. Hyun has guided students and researchers, cultivating future scientists in the field of neuroscience.

Awards and Honors:

Dr. Jung Ho Hyun has received numerous prestigious awards throughout his career. In 2021, he was awarded the Travel Award at the 44th Annual Meeting of the Japan Neuroscience Society. His work has also been recognized with the 2019 Gill Symposium Travel Award, which supported his research contributions at a global level. In 2018, he received the Korean American Society in Biotech and Pharmaceuticals Fellowship Award, recognizing his outstanding research contributions in the field of neuroscience. Dr. Hyun was also granted the Max Planck Florida Institute for Neuroscience (MPFI) Travel Grant in 2018, facilitating further academic collaborations. These honors reflect the recognition and respect Dr. Hyun has earned within the scientific community, underscoring his commitment to advancing neuroscience research. His consistent pursuit of excellence is further exemplified by his leadership in mentoring and scientific outreach efforts.

Research Focus:

Dr. Jung Ho Hyun’s research focuses on understanding the neural mechanisms underlying cognitive flexibility, memory, and complex behavioral processes. His work explores how memory is stored and retrieved in the brain and how neural circuits contribute to cognitive processes such as decision-making and behavioral flexibility. Dr. Hyun’s lab utilizes molecular tools, including genetically encoded calcium indicators, to track and manipulate neuronal activity at the cellular and circuit level. One of his key areas of focus is understanding how neural populations encode and process information, particularly in regions like the orbitofrontal cortex. His research aims to uncover how manipulating neural ensembles can help treat brain illnesses and disorders. Dr. Hyun’s contributions to the development of new methods to study neural activity have positioned him at the forefront of neurophysiological research, with significant potential for clinical applications.

Publications Top Notes:

  1. Eom K#, Kim D#, Hyun JH* (2025) “Engram and behavior: How memory is stored in the brain.” 🧠📚 Neurobiology of Learning and Memory.
  2. Eom K, Jung J#, Kim B#, Hyun JH* (2024) “Molecular tools for recording and intervention of neuronal activity.” 🧬🔬 Molecules and Cells.
  3. Hyun JH, Hannan P, Iwamoto H, Blakely R, Kwon H-B (2023) “Serotonin in the orbitofrontal cortex enhances cognitive flexibility.” 🧠💡 bioRxiv.
  4. Hyun JH#, Nagahama K#, Ho N#, Mignocchi N, Roh S-E, Hannan P, Krüssel S, Kwak C, McElroy A, Liu B, Cui M, Lee S, Lee D, Huganir RL, Worley PF, Sawa A, Kwon H-B (2022) “Tagging active neurons by soma-targeted Cal-Light.” 🔦🧬 Nature Communications.
  5. Eom K#, Lee HR#, Hyun JH, Ryu H-H, Lee Y-S, Ho W-K, Lee S-H (2021) “Gradual decorrelation of CA3 ensembles associated with contextual discrimination learning is impaired by Kv1.2 insufficiency.” 🔬📊 Hippocampus.

Conclusion:

Dr. Jung Ho Hyun is an excellent candidate for the Best Researcher Award due to his innovative research, exceptional contributions to neuroscience, and strong leadership. His multidisciplinary approach to understanding cognitive flexibility and memory, along with his pioneering use of molecular tools to study neural circuits, sets him apart as a leader in his field.

Fucheng Lin | Microbial Cell Biology | Best Researcher Award

Published on by Cell Biologist

Prof. Fucheng Lin | Microbial Cell Biology | Best Researcher Award

Prof. Fucheng Lin , Zhejiang Academy of Agricultural Sciences (ZAAS) , China

Lin Fu-Cheng is a distinguished professor and president at the Zhejiang Academy of Agricultural Sciences, specializing in the prevention and control of plant fungal diseases. His groundbreaking research on the pathogenic mechanisms of fungi, immune systemic resistance in plants, and the development of disease-resistant crops has earned him numerous accolades, including the prestigious National Science Fund for Distinguished Young Scholars. With over 13,000 citations, he is a leading figure in agricultural science. He has contributed significantly to the understanding of plant fungal diseases, with notable innovations in disease-resistant germplasm and sustainable agricultural practices. He holds several important editorial roles, including as chief editor for prominent journals. Lin Fu-Cheng’s collaborative efforts in research have positioned him as a key scientist in various national and international agricultural research projects.

Publication Profile: 

Orcid

Strengths for the Award:

  1. Outstanding Research Contributions:

    • Lin Fu-Cheng has made groundbreaking contributions in the field of plant pathology, especially in understanding the pathogenic mechanisms of plant fungal diseases. His pioneering work on the relationship between autophagy and pathogenicity in Magnaporthe oryzae has opened new avenues for research on plant pathogenic fungi.
    • His establishment of a novel evolutionary model between endophytic fungi, pathogenic fungi, and plants has furthered sustainable disease management strategies, especially for rice blast, a major threat to rice production globally.
    • Fu-Cheng has creatively integrated interspecific hybridization techniques to create disease-resistant germplasm, enhancing agricultural sustainability.

  2. Innovative Approach to Disease Control:

    • His work using endophytic fungi to induce immunity in rice represents a shift toward environmentally sustainable disease management practices. This innovative strategy offers a promising alternative to chemical-based interventions and aligns with the global push for green agricultural development.

  3. Recognition and Impact:

    • With more than 13,000 citations and over 280 published papers in high-impact journals, Fu-Cheng’s research has had a significant influence on the scientific community. His citation index of over 10,000 demonstrates the global recognition of his work.
    • He has led several major research projects, including national and provincial projects focused on agricultural technology, demonstrating his leadership and expertise.

  4. Leadership and Mentorship:

    • As a professor and doctoral supervisor, Fu-Cheng has mentored numerous students, many of whom are actively contributing to research in related fields. His leadership roles in both national and international scientific organizations further solidify his stature in the research community.

  5. High-Impact Publications and Patents:

    • Fu-Cheng has published over 195 SCI papers and holds 141 patents, many of which have been applied industrially. His contributions to both the academic and practical sides of plant protection are noteworthy.

Areas for Improvement:

  1. Broader Collaboration Across Disciplines:

    • While Fu-Cheng has demonstrated exceptional leadership in his field, expanding collaborations with researchers from other disciplines, such as environmental science and agronomy, could further enhance the applicability and scope of his research in global agricultural practices.

  2. Global Outreach and Dissemination:

    • Though Fu-Cheng’s research is highly impactful, increased visibility in global agricultural policy-making circles could ensure his innovative solutions reach a broader audience. Collaborating with international organizations and policymakers could facilitate the adoption of his findings on a larger scale, particularly in regions most affected by rice blast.

  3. Integration of Climate Change Research:

    • Given the ongoing challenges posed by climate change to agricultural productivity, Fu-Cheng’s future research could benefit from focusing on how climate factors influence the pathogenicity of plant diseases, especially in the context of shifting agricultural practices.

Education:

Lin Fu-Cheng earned his Ph.D. in Plant Pathology and Microbiology from Zhejiang University, China. Over the years, his academic training and postdoctoral research have helped shape his expertise in plant disease control and fungal pathology. As a doctoral supervisor, he has mentored numerous students, guiding them in the realms of agricultural science, plant protection, and microbiology. His rigorous academic foundation in both theoretical research and applied science has laid the groundwork for his leadership in significant projects related to the management of biotic threats to agro-product safety. Lin’s educational journey also involved extensive international collaboration, which broadened his scientific perspectives and fostered a strong commitment to advancing agricultural technology on a global scale.

Experience:

Lin Fu-Cheng is a seasoned academic and research leader with over two decades of experience in the field of plant protection and microbiology. He has presided over numerous high-impact research projects, including national and provincial funding programs. His leadership as the chief scientist in national key research and development programs has contributed substantially to the development of new methodologies for managing plant diseases, particularly fungal pathogens. Lin has been instrumental in bridging academia and industry through his involvement in over 17 consultancy and industry-related projects. His work on the development of disease-resistant crops and innovative agricultural practices has gained widespread recognition. He has also contributed significantly to various scientific journals, where his editorial roles have allowed him to shape the direction of research in plant pathology. Lin’s vast experience in managing large-scale research initiatives has made him a respected figure in agricultural sciences both in China and internationally.

Research Focus:

Lin Fu-Cheng’s research focuses on plant fungal diseases, with a particular emphasis on the pathogenic mechanisms of fungi, immunity induction by endophytic fungi, and the creation of disease-resistant crops. His pioneering work on autophagy in Magnaporthe oryzae has opened new avenues in understanding fungal pathogenicity. He established a groundbreaking model for the interaction between endophytic fungi, pathogenic fungi, and plants, which provides insights into sustainable disease management practices. Additionally, Lin has combined interspecific hybridization with disease-resistant germplasm innovation, contributing to the development of crops that are more resilient to fungal diseases. His research integrates both theoretical studies and practical applications, aimed at enhancing agricultural productivity and promoting the green development of agriculture. With his vast contributions to plant protection, Lin is at the forefront of research that seeks to mitigate the impact of plant diseases on global food security.

Publication Top Notes:

  • A glance at structural biology in advancing rice blast fungus research 🧬
  • A key sphingolipid pathway gene, MoDES1, regulates conidiation, virulence, and plasma membrane tension in Magnaporthe oryzae 🌱
  • A pair of nuclear factor Y transcription factors act as positive regulators in jasmonate signaling and disease resistance in Arabidopsis 🌾
  • A repressive H3K36me2 reader mediates Polycomb silencing 🔬
  • A rho-type GTPase activating protein affects the growth and development of Cordyceps cicadae 🍄
  • A Taxonomic Study of Candolleomyces Specimens from China Revealed Seven New Species 🌿
  • Actin-related protein MoFim1 modulated the pathogenicity of Magnaporthe oryzae by controlling three MAPK signaling pathways, appressorium formation, and hydrophobicity 🧪
  • Cand2 inhibits CRL-mediated ubiquitination and suppresses autophagy to facilitate pathogenicity of phytopathogenic fungi 💡
  • Csn5 inhibits autophagy by regulating the ubiquitination of Atg6 and Tor to mediate the pathogenicity of Magnaporthe oryzae 🦠
  • DGK5 6-derived phosphatidic acid regulates ROS production in plant immunity by stabilizing NADPH oxidase 🌟

Conclusion:

Lin Fu-Cheng’s achievements in plant pathology are not only groundbreaking but also have significant practical implications for sustainable agricultural practices. His research has laid the foundation for innovative disease management strategies, and his work on autophagy, endophytic fungi, and disease-resistant germplasm is leading the way toward more eco-friendly agricultural solutions. His strong academic record, leadership, and contributions to the field make him a highly deserving candidate for the Best Researcher Award. Expanding his collaborations and outreach efforts could further amplify his impact on global agricultural sustainability.

Sheng-Chi Hsu | molecular diagnosis | Best Researcher Award

Published on by Cell Biologist

Mrs. Sheng-Chi Hsu | molecular diagnosis | Best Researcher Award

Mrs. Sheng-Chi Hsu , Department of Laboratory Medicaine, Chang Gung Memorial Hospital at LinKou , Taiwan

Sheng-Chi Hsu, M.S., is a leading expert in tumor biology, molecular pathology, and personalized medicine. Currently serving as the Deputy Director of the Department of Laboratory Medicine at Chang Gung Memorial Hospital, Linkou Branch, he has extensive experience in cancer diagnostics, molecular pathology, and clinical research. With a strong academic background and a commitment to advancing medical science, Hsu has contributed significantly to the field of oncology, focusing on novel diagnostic approaches and precision medicine strategies. His research has resulted in several impactful publications, enhancing diagnostic accuracy and the development of targeted therapies for various cancers. Hsu’s work has played a pivotal role in improving patient outcomes and shaping the future of cancer treatment in Taiwan.

Publication Profile: 

Scopus

Strengths for the Award:

Sheng-Chi Hsu has demonstrated exceptional expertise in tumor biology, molecular pathology, and personalized medicine, contributing to groundbreaking advancements in cancer diagnostics and precision medicine. His leadership roles at Chang Gung Memorial Hospital, particularly in the Department of Laboratory Medicine and Pathology, showcase his ability to manage large teams and oversee complex laboratory operations while pushing the boundaries of research. His publications in prestigious journals highlight significant research achievements, including the identification of key biomarkers for cancer therapies and advancing molecular diagnostic techniques. Hsu’s research on cancer biomarkers, including ALK translocation and ROS1 translocation in non-small cell lung cancer (NSCLC), has provided valuable insights into targeted therapies, which are directly influencing patient care and therapeutic approaches. His work on multidrug resistance also opens new therapeutic avenues to overcome chemotherapy resistance, making his contributions pivotal to modern cancer treatment strategies.

Areas for Improvements:

While Hsu’s research accomplishments are impressive, expanding his involvement in large-scale, multi-center clinical trials could further enhance the real-world application and validation of his research findings. Collaborating with international institutions or expanding his research scope to include more diverse populations may also increase the generalizability and impact of his findings. Additionally, although Hsu has an extensive background in molecular diagnostics, there may be room to explore emerging technologies, such as artificial intelligence in pathology, to further optimize diagnostic procedures and improve precision medicine outcomes.

Experience:

Sheng-Chi Hsu has over 15 years of experience in laboratory medicine and pathology, with expertise in tumor pathology and molecular diagnostics. He is currently the Deputy Director of the Department of Laboratory Medicine at Chang Gung Memorial Hospital, where he leads research and development in laboratory diagnostics. Previously, he served as the Deputy Director of the Department of Pathology, overseeing innovations in histopathological diagnostics. Hsu’s leadership has been instrumental in advancing cancer diagnostics, optimizing molecular diagnostic techniques, and improving laboratory workflows. His career also includes roles as a Chief and Senior Medical Technologist, where he pioneered research in tumor pathology, focusing on biomarker identification and the development of diagnostic assays.

Research Focus:

Sheng-Chi Hsu’s research focuses on advancing molecular diagnostics, particularly in oncology. His work aims to enhance diagnostic precision for various cancers, with a strong emphasis on personalized medicine. Hsu has made significant contributions to the genetic characterization of tumors, identifying key biomarkers for targeted therapies in non-small cell lung cancer (NSCLC), synovial sarcoma, and gestational trophoblastic disease. His research in multidrug resistance mechanisms and the role of Wnt5A in cancer therapy has opened new avenues for overcoming chemoresistance. Hsu’s pioneering studies in molecular pathology have significantly impacted clinical practices, helping improve treatment strategies and patient outcomes through advanced diagnostics.

Publications Top Notes:

  1. Wang HS, Liu CY, Hsu SC, Huang SC, Hung TH, Ng KF, Chen TC. A Single-Institute Experience with C-ros Oncogene 1 Translocation in Non-Small Cell Lung Cancers in Taiwan. Int J Mol Sci. 2022 May 21;23(10):5789. 📄
  2. Hsu SC, Hung TH, Wang CW, Ng KF, Chen TC. Anaplastic lymphoma kinase translocation is correlated with anaplastic lymphoma kinase expression and mutually exclusive with epidermal growth factor receptor mutation in Taiwanese non-small cell lung cancer. Pathol Int. 2015 May;65(5):231-9. 📄
  3. Hung TH, Hsu SC, Cheng CY, Choo KB, Tseng CP, Chen TC, Lan YW, Huang TT, Lai HC, Chen CM, Chong KY. Wnt5A regulates ABCB1 expression in multidrug-resistant cancer cells through activation of the non-canonical PKA/β-catenin pathway. Oncotarget. 2014 Dec 15;5(23):12273-90. 📄
  4. Chen KH, Hsu SC, Chen HY, Ng KF, Chen TC. Utility of fluorescence in situ hybridization for ploidy and p57 immunostaining in discriminating hydatidiform moles. Biochem Biophys Res Commun. 2014 Apr 4;446(2):555-60. 📄
  5. Chuang HC, Hsu SC, Huang CG, Hsueh S, Ng KF, Chen TC. Reappraisal of TLE-1 immunohistochemical staining and molecular detection of SS18-SSX fusion transcripts for synovial sarcoma. Pathol Int. 2013 Dec;63(12):573-80. 📄

Conclusion:

Sheng-Chi Hsu is highly deserving of the “Best Researcher Award” due to his outstanding contributions to cancer research and diagnostic advancements. His innovative approach to tumor pathology and molecular diagnostics, along with his leadership in clinical and research operations, makes him a transformative figure in the field. With a continued focus on expanding his research scope and incorporating emerging technologies, Hsu’s impact on personalized cancer treatments is poised to grow even further.